HNGE Hinge Health, Inc.

NYSE www.hingehealth.com


$ 40.91 $ 0.36 (0.89 %)    

Monday, 17-Nov-2025 13:46:43 EST
QQQ $ 607.04 $ 0.90 (0.15 %)
DIA $ 469.69 $ -1.17 (-0.25 %)
SPY $ 669.45 $ -0.28 (-0.04 %)
TLT $ 89.14 $ 0.06 (0.07 %)
GLD $ 374.33 $ 0.33 (0.09 %)
$ 40.96
$ 40.71
$ 40.87 x 200
$ 40.99 x 350
$ 40.34 - $ 41.61
$ 33.42 - $ 62.18
1,861,097
na
3.23B
nm
nm
TBD
na
na (nm)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-07-2025 09-30-2025 10-Q
2 08-11-2025 06-30-2025 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Canaccord Genuity analyst Richard Close maintains Hinge Health (NYSE:HNGE) with a Buy and raises the price target from $61 t...

Core News & Articles

Barclays analyst Saket Kalia maintains Hinge Health (NYSE:HNGE) with a Overweight and raises the price target from $62 to $65.

Core News & Articles

Piper Sandler analyst Jessica Tassan reiterates Hinge Health (NYSE:HNGE) with a Overweight and raises the price target from ...

Core News & Articles

Hinge Health (NYSE:HNGE) raises FY2025 sales outlook from $548.000 million-$552.000 million to $572.000 million-$574.000 millio...

Core News & Articles

Hinge Health (NYSE:HNGE) sees Q4 sales of $155.000 million-$157.000 million vs $145.468 million analyst estimate.

Core News & Articles

Hinge Health (NYSE:HNGE) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.15) by...

Core News & Articles

Evercore ISI Group analyst Elizabeth Anderson maintains Hinge Health (NYSE:HNGE) with a Outperform and raises the price targ...

 trump-administration-review-targets-medical-supply-chain-vulnerabilities

The U.S. Commerce Department, under the Trump administration, has launched a national security review of medical imports—includ...

Core News & Articles

Morgan Stanley analyst Craig Hettenbach maintains Hinge Health (NYSE:HNGE) with a Overweight and raises the price target fro...

Core News & Articles

Stifel analyst David Grossman maintains Hinge Health (NYSE:HNGE) with a Buy and raises the price target from $63 to $66.

Core News & Articles

Baird analyst Vikram Kesavabhotla initiates coverage on Hinge Health (NYSE:HNGE) with a Neutral rating and announces Price T...

Core News & Articles

Canaccord Genuity analyst Richard Close maintains Hinge Health (NYSE:HNGE) with a Buy and raises the price target from $52 t...

Core News & Articles

JMP Securities analyst Aaron Kimson maintains Hinge Health (NYSE:HNGE) with a Market Outperform and raises the price target ...

Core News & Articles

Barclays analyst Saket Kalia maintains Hinge Health (NYSE:HNGE) with a Overweight and raises the price target from $51 to $62.

Core News & Articles

Evercore ISI Group analyst Elizabeth Anderson maintains Hinge Health (NYSE:HNGE) with a Outperform and raises the price targ...

Core News & Articles

Needham analyst Ryan MacDonald maintains Hinge Health (NYSE:HNGE) with a Buy and raises the price target from $47 to $59.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION